Von der Leyen says the EU has reached the target of the COVID vaccine | Coronavirus News Plague

EU President Ursula von der Leyen urges members to increase vaccinations as the Delta coronavirus species spreads throughout the region.

The European Union has provided enough coronavirus vaccines to member states to achieve a vaccination rate of 70% of adults in the bloc, said European Commission chief Ursula von der Leyen.

Von der Leyen, who wrote on May 9 that the EU was on track to achieve its goal of enrolling 70% of seniors by summer, urged EU countries to increase immunization and said about 500 million units would be distributed by the agreement by Sunday.

“The European Union has kept its promise. This week we have provided enough vaccinations to member states to provide about 70% of EU officials this month, “von der Leyen said in a statement on Saturday.

“But COVID-19 has not been defeated. We are ready to offer more vaccines, including newer varieties, “said von der Leyen, who was criticized in early 2021 for failing to ensure that companies offered supportive vaccines.

Goals achieved!

We have provided enough vaccines to EU countries to vaccinate at least 70% of EU officials this month.

COVID-19 has not yet been won. But we are ready to give more vaccines.

We’ll just get out of this mess together.
#SafeVaccines pic.twitter.com/5yYCtbqBxc

– Ursula von der Leyen (@vonderleyen) July 10, 2021

The EU vaccination program, run by the European Commission, has provided 330 million BioNTech-Pfizer shots, 100 million AstraZeneca Doses, 50 million from Moderna and 20 million Johnson & Johnson shots.

The goal of the long-term bloc is to have enough vaccines to protect all eligible people by the end of September.

Von der Leyen added in a recent statement that the EU was ready to offer more standards, including vaccines against new species.

Sonia Gallegos of Al Jazeera, speaking from London, said that despite the success of the EU vaccine, there are still real concerns about Delta’s mutation for coronavirus, first recorded in India.

“There is another type of transmission in Delta, which could sweep the entire contract, which is why it is encouraging member states to continue developing their vaccine,” Gallegos said.

The EU is he was first rebuked some due to delays in negotiating agreements with drug suppliers, and the plan was later thwarted when other companies – particularly UK-based AstraZeneca – failed to deliver.

But, as the industry rushed to expand the newly developed vaccine, purchases began to creep in.

The Commission said last week EU countries ordered about 40 million vaccines produced by Johnson & Johnson.

The Commission has already warned that it expects the Delta’s coronavirus to rule Europe in the summer, based on a comparison from the EU’s immunization agency.